Loading…
miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma
The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasivene...
Saved in:
Published in: | Cancer letters 2020-05, Vol.477, p.49-59 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753 |
---|---|
cites | cdi_FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753 |
container_end_page | 59 |
container_issue | |
container_start_page | 49 |
container_title | Cancer letters |
container_volume | 477 |
creator | Molist, C. Navarro, N. Giralt, I. Zarzosa, P. Gallo-Oller, G. Pons, G. Magdaleno, A. Moreno, L. Guillén, G. Hladun, R. Garrido, M. Soriano, A. Segura, M.F. Sánchez de Toledo, J. Gallego, S. Roma, J. |
description | The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasiveness. Despite the consensus on the remarkable pro-oncogenic potential of this protein, the miRNA-mediated regulation of ITGA9 has barely been studied to date. In the present study, miR-7 and miR-324-5p were selected as the best candidates after a screening to find ITGA9 regulators, and their effects on cell proliferation and invasion in RMS are described and characterized for the first time. Interestingly, the overexpression of both miRNA produced a clear impairment of cell proliferation, while miR-7 also induced a remarkable drop in cell invasion. Furthermore, the stable overexpression of both miRNA was found to reduce tumor growth in orthotopic RMS models and miR-7 was able to impair metastatic lung colonization. Consequently, we conclude that miR-7 and miR-324-5p show anti-oncogenic and anti-metastatic potential, thereby opening up the possibility of being used as novel therapeutic tools to avoid RMS progression.
[Display omitted]
•miR-7 and miR-324-5p are described for the first time as ITGA9 regulators in RMS.•miR-7 and miR-324-5p have a clear role in cell proliferation.•miR-7 has a crucial role in cell invasion, both in vitro and in vivo.•The animal models provided confirms a crucial in vivo role of both miRNA. |
doi_str_mv | 10.1016/j.canlet.2020.02.035 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2374316628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030438352030104X</els_id><sourcerecordid>2374316628</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753</originalsourceid><addsrcrecordid>eNp9kUtr3TAQRkVpaG7T_oNSDN10I0dPW9oUQugjEBoI7VrI8vhGF1tyJDsk_766ddpFF11pBs43GuYg9I6SmhLanB9qZ8MIS80IIzVhNeHyBdpR1TLcakVeoh3hRGCuuDxFr3M-EEKkaOUrdMoZFUxTvUP3k7_9foHbyoa-2mrOBJZzlWC_jnaByo7zndX4KiywTz5U8DgnyNnH8DsEj5CWUi0ex-DiHoJ3FQwDuCVXBU93tuvj9BSzTS5O9g06GeyY4e3ze4Z-fvn84_Ibvr75enV5cY2dEHTBumENER1o55xyTHW0c7xrOmYHUL3r5dBKsJY5wbXUx6ZjLVCQDVV9afkZ-rjNnVO8XyEvZvLZwTjaAHHNhvFWcNo0TBX0wz_oIa4plO0ME0w2SmjKCyU2yqWYc4LBzMlPNj0ZSsxRiTmYTYk5KjGEmaKkxN4_D1-7Cfq_oT8OCvBpA6Bc48FDMtl5CA56n8oRTR_9_3_4BRoEnoE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425684913</pqid></control><display><type>article</type><title>miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Molist, C. ; Navarro, N. ; Giralt, I. ; Zarzosa, P. ; Gallo-Oller, G. ; Pons, G. ; Magdaleno, A. ; Moreno, L. ; Guillén, G. ; Hladun, R. ; Garrido, M. ; Soriano, A. ; Segura, M.F. ; Sánchez de Toledo, J. ; Gallego, S. ; Roma, J.</creator><creatorcontrib>Molist, C. ; Navarro, N. ; Giralt, I. ; Zarzosa, P. ; Gallo-Oller, G. ; Pons, G. ; Magdaleno, A. ; Moreno, L. ; Guillén, G. ; Hladun, R. ; Garrido, M. ; Soriano, A. ; Segura, M.F. ; Sánchez de Toledo, J. ; Gallego, S. ; Roma, J.</creatorcontrib><description>The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasiveness. Despite the consensus on the remarkable pro-oncogenic potential of this protein, the miRNA-mediated regulation of ITGA9 has barely been studied to date. In the present study, miR-7 and miR-324-5p were selected as the best candidates after a screening to find ITGA9 regulators, and their effects on cell proliferation and invasion in RMS are described and characterized for the first time. Interestingly, the overexpression of both miRNA produced a clear impairment of cell proliferation, while miR-7 also induced a remarkable drop in cell invasion. Furthermore, the stable overexpression of both miRNA was found to reduce tumor growth in orthotopic RMS models and miR-7 was able to impair metastatic lung colonization. Consequently, we conclude that miR-7 and miR-324-5p show anti-oncogenic and anti-metastatic potential, thereby opening up the possibility of being used as novel therapeutic tools to avoid RMS progression.
[Display omitted]
•miR-7 and miR-324-5p are described for the first time as ITGA9 regulators in RMS.•miR-7 and miR-324-5p have a clear role in cell proliferation.•miR-7 has a crucial role in cell invasion, both in vitro and in vivo.•The animal models provided confirms a crucial in vivo role of both miRNA.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2020.02.035</identifier><identifier>PMID: 32142919</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Adapter proteins ; Animals ; Antibodies ; Brain cancer ; Cell adhesion & migration ; Cell Line, Tumor ; Cell proliferation ; Cell Proliferation - genetics ; Chromosomes ; Cloning ; Colonization ; Doxycycline - pharmacology ; Focal Adhesion Kinase 1 - genetics ; Focal Adhesion Kinase 1 - metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Integrins ; Integrins - genetics ; Invasiveness ; ITGA9 ; Kinases ; Laboratories ; Ligands ; Medical prognosis ; Melanoma ; Metastases ; Metastasis ; Mice, SCID ; MicroRNAs ; MicroRNAs - genetics ; miRNA ; Pediatric cancer ; Pediatrics ; Phosphorylation ; Prognosis ; Rhabdomyosarcoma ; Rhabdomyosarcoma - drug therapy ; Rhabdomyosarcoma - genetics ; Rhabdomyosarcoma - pathology ; RNA, Small Interfering ; Soft tissue sarcoma ; Xenograft Model Antitumor Assays</subject><ispartof>Cancer letters, 2020-05, Vol.477, p.49-59</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><rights>2020. Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753</citedby><cites>FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32142919$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Molist, C.</creatorcontrib><creatorcontrib>Navarro, N.</creatorcontrib><creatorcontrib>Giralt, I.</creatorcontrib><creatorcontrib>Zarzosa, P.</creatorcontrib><creatorcontrib>Gallo-Oller, G.</creatorcontrib><creatorcontrib>Pons, G.</creatorcontrib><creatorcontrib>Magdaleno, A.</creatorcontrib><creatorcontrib>Moreno, L.</creatorcontrib><creatorcontrib>Guillén, G.</creatorcontrib><creatorcontrib>Hladun, R.</creatorcontrib><creatorcontrib>Garrido, M.</creatorcontrib><creatorcontrib>Soriano, A.</creatorcontrib><creatorcontrib>Segura, M.F.</creatorcontrib><creatorcontrib>Sánchez de Toledo, J.</creatorcontrib><creatorcontrib>Gallego, S.</creatorcontrib><creatorcontrib>Roma, J.</creatorcontrib><title>miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasiveness. Despite the consensus on the remarkable pro-oncogenic potential of this protein, the miRNA-mediated regulation of ITGA9 has barely been studied to date. In the present study, miR-7 and miR-324-5p were selected as the best candidates after a screening to find ITGA9 regulators, and their effects on cell proliferation and invasion in RMS are described and characterized for the first time. Interestingly, the overexpression of both miRNA produced a clear impairment of cell proliferation, while miR-7 also induced a remarkable drop in cell invasion. Furthermore, the stable overexpression of both miRNA was found to reduce tumor growth in orthotopic RMS models and miR-7 was able to impair metastatic lung colonization. Consequently, we conclude that miR-7 and miR-324-5p show anti-oncogenic and anti-metastatic potential, thereby opening up the possibility of being used as novel therapeutic tools to avoid RMS progression.
[Display omitted]
•miR-7 and miR-324-5p are described for the first time as ITGA9 regulators in RMS.•miR-7 and miR-324-5p have a clear role in cell proliferation.•miR-7 has a crucial role in cell invasion, both in vitro and in vivo.•The animal models provided confirms a crucial in vivo role of both miRNA.</description><subject>Adapter proteins</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Brain cancer</subject><subject>Cell adhesion & migration</subject><subject>Cell Line, Tumor</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - genetics</subject><subject>Chromosomes</subject><subject>Cloning</subject><subject>Colonization</subject><subject>Doxycycline - pharmacology</subject><subject>Focal Adhesion Kinase 1 - genetics</subject><subject>Focal Adhesion Kinase 1 - metabolism</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Integrins</subject><subject>Integrins - genetics</subject><subject>Invasiveness</subject><subject>ITGA9</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>Ligands</subject><subject>Medical prognosis</subject><subject>Melanoma</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mice, SCID</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>miRNA</subject><subject>Pediatric cancer</subject><subject>Pediatrics</subject><subject>Phosphorylation</subject><subject>Prognosis</subject><subject>Rhabdomyosarcoma</subject><subject>Rhabdomyosarcoma - drug therapy</subject><subject>Rhabdomyosarcoma - genetics</subject><subject>Rhabdomyosarcoma - pathology</subject><subject>RNA, Small Interfering</subject><subject>Soft tissue sarcoma</subject><subject>Xenograft Model Antitumor Assays</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kUtr3TAQRkVpaG7T_oNSDN10I0dPW9oUQugjEBoI7VrI8vhGF1tyJDsk_766ddpFF11pBs43GuYg9I6SmhLanB9qZ8MIS80IIzVhNeHyBdpR1TLcakVeoh3hRGCuuDxFr3M-EEKkaOUrdMoZFUxTvUP3k7_9foHbyoa-2mrOBJZzlWC_jnaByo7zndX4KiywTz5U8DgnyNnH8DsEj5CWUi0ex-DiHoJ3FQwDuCVXBU93tuvj9BSzTS5O9g06GeyY4e3ze4Z-fvn84_Ibvr75enV5cY2dEHTBumENER1o55xyTHW0c7xrOmYHUL3r5dBKsJY5wbXUx6ZjLVCQDVV9afkZ-rjNnVO8XyEvZvLZwTjaAHHNhvFWcNo0TBX0wz_oIa4plO0ME0w2SmjKCyU2yqWYc4LBzMlPNj0ZSsxRiTmYTYk5KjGEmaKkxN4_D1-7Cfq_oT8OCvBpA6Bc48FDMtl5CA56n8oRTR_9_3_4BRoEnoE</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Molist, C.</creator><creator>Navarro, N.</creator><creator>Giralt, I.</creator><creator>Zarzosa, P.</creator><creator>Gallo-Oller, G.</creator><creator>Pons, G.</creator><creator>Magdaleno, A.</creator><creator>Moreno, L.</creator><creator>Guillén, G.</creator><creator>Hladun, R.</creator><creator>Garrido, M.</creator><creator>Soriano, A.</creator><creator>Segura, M.F.</creator><creator>Sánchez de Toledo, J.</creator><creator>Gallego, S.</creator><creator>Roma, J.</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20200501</creationdate><title>miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma</title><author>Molist, C. ; Navarro, N. ; Giralt, I. ; Zarzosa, P. ; Gallo-Oller, G. ; Pons, G. ; Magdaleno, A. ; Moreno, L. ; Guillén, G. ; Hladun, R. ; Garrido, M. ; Soriano, A. ; Segura, M.F. ; Sánchez de Toledo, J. ; Gallego, S. ; Roma, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adapter proteins</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Brain cancer</topic><topic>Cell adhesion & migration</topic><topic>Cell Line, Tumor</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - genetics</topic><topic>Chromosomes</topic><topic>Cloning</topic><topic>Colonization</topic><topic>Doxycycline - pharmacology</topic><topic>Focal Adhesion Kinase 1 - genetics</topic><topic>Focal Adhesion Kinase 1 - metabolism</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Integrins</topic><topic>Integrins - genetics</topic><topic>Invasiveness</topic><topic>ITGA9</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>Ligands</topic><topic>Medical prognosis</topic><topic>Melanoma</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mice, SCID</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>miRNA</topic><topic>Pediatric cancer</topic><topic>Pediatrics</topic><topic>Phosphorylation</topic><topic>Prognosis</topic><topic>Rhabdomyosarcoma</topic><topic>Rhabdomyosarcoma - drug therapy</topic><topic>Rhabdomyosarcoma - genetics</topic><topic>Rhabdomyosarcoma - pathology</topic><topic>RNA, Small Interfering</topic><topic>Soft tissue sarcoma</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Molist, C.</creatorcontrib><creatorcontrib>Navarro, N.</creatorcontrib><creatorcontrib>Giralt, I.</creatorcontrib><creatorcontrib>Zarzosa, P.</creatorcontrib><creatorcontrib>Gallo-Oller, G.</creatorcontrib><creatorcontrib>Pons, G.</creatorcontrib><creatorcontrib>Magdaleno, A.</creatorcontrib><creatorcontrib>Moreno, L.</creatorcontrib><creatorcontrib>Guillén, G.</creatorcontrib><creatorcontrib>Hladun, R.</creatorcontrib><creatorcontrib>Garrido, M.</creatorcontrib><creatorcontrib>Soriano, A.</creatorcontrib><creatorcontrib>Segura, M.F.</creatorcontrib><creatorcontrib>Sánchez de Toledo, J.</creatorcontrib><creatorcontrib>Gallego, S.</creatorcontrib><creatorcontrib>Roma, J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Molist, C.</au><au>Navarro, N.</au><au>Giralt, I.</au><au>Zarzosa, P.</au><au>Gallo-Oller, G.</au><au>Pons, G.</au><au>Magdaleno, A.</au><au>Moreno, L.</au><au>Guillén, G.</au><au>Hladun, R.</au><au>Garrido, M.</au><au>Soriano, A.</au><au>Segura, M.F.</au><au>Sánchez de Toledo, J.</au><au>Gallego, S.</au><au>Roma, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>477</volume><spage>49</spage><epage>59</epage><pages>49-59</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasiveness. Despite the consensus on the remarkable pro-oncogenic potential of this protein, the miRNA-mediated regulation of ITGA9 has barely been studied to date. In the present study, miR-7 and miR-324-5p were selected as the best candidates after a screening to find ITGA9 regulators, and their effects on cell proliferation and invasion in RMS are described and characterized for the first time. Interestingly, the overexpression of both miRNA produced a clear impairment of cell proliferation, while miR-7 also induced a remarkable drop in cell invasion. Furthermore, the stable overexpression of both miRNA was found to reduce tumor growth in orthotopic RMS models and miR-7 was able to impair metastatic lung colonization. Consequently, we conclude that miR-7 and miR-324-5p show anti-oncogenic and anti-metastatic potential, thereby opening up the possibility of being used as novel therapeutic tools to avoid RMS progression.
[Display omitted]
•miR-7 and miR-324-5p are described for the first time as ITGA9 regulators in RMS.•miR-7 and miR-324-5p have a clear role in cell proliferation.•miR-7 has a crucial role in cell invasion, both in vitro and in vivo.•The animal models provided confirms a crucial in vivo role of both miRNA.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>32142919</pmid><doi>10.1016/j.canlet.2020.02.035</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-3835 |
ispartof | Cancer letters, 2020-05, Vol.477, p.49-59 |
issn | 0304-3835 1872-7980 |
language | eng |
recordid | cdi_proquest_miscellaneous_2374316628 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Adapter proteins Animals Antibodies Brain cancer Cell adhesion & migration Cell Line, Tumor Cell proliferation Cell Proliferation - genetics Chromosomes Cloning Colonization Doxycycline - pharmacology Focal Adhesion Kinase 1 - genetics Focal Adhesion Kinase 1 - metabolism Gene Expression Regulation, Neoplastic Humans Integrins Integrins - genetics Invasiveness ITGA9 Kinases Laboratories Ligands Medical prognosis Melanoma Metastases Metastasis Mice, SCID MicroRNAs MicroRNAs - genetics miRNA Pediatric cancer Pediatrics Phosphorylation Prognosis Rhabdomyosarcoma Rhabdomyosarcoma - drug therapy Rhabdomyosarcoma - genetics Rhabdomyosarcoma - pathology RNA, Small Interfering Soft tissue sarcoma Xenograft Model Antitumor Assays |
title | miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A02%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miRNA-7%20and%20miRNA-324-5p%20regulate%20alpha9-Integrin%20expression%20and%20exert%20anti-oncogenic%20effects%20in%20rhabdomyosarcoma&rft.jtitle=Cancer%20letters&rft.au=Molist,%20C.&rft.date=2020-05-01&rft.volume=477&rft.spage=49&rft.epage=59&rft.pages=49-59&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2020.02.035&rft_dat=%3Cproquest_cross%3E2374316628%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2425684913&rft_id=info:pmid/32142919&rfr_iscdi=true |